{"disease":{"id":"genital-warts","name":"genital warts"},"drugs":{"marketed":[{"drug_id":"podophyllotoxin","indication_name":"Topical treatment of anogenital warts","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Condylox","generic_name":"podophyllotoxin","company_name":"Actavis Labs Ut Inc","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"podophyllotoxin","quality_score":60,"revenue":null,"mechanism":"Condylox works by disrupting cell division and preventing the growth of abnormal cells."},{"drug_id":"podofilox","indication_name":"Topical treatment of anogenital warts","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PODOFILOX","company_name":"","drug_phase":"marketed","molecular_target":"Unknown","drug_class":"Topical antiviral","quality_score":60,"revenue":null,"mechanism":"Podofilox induces necrosis of anogenital wart tissue, though the exact mechanism is unknown."},{"drug_id":"podophyllum-resin","indication_name":"Removal of soft genital warts","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PODOPHYLLUM RESIN","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":10,"revenue":null,"mechanism":null},{"drug_id":"podofilox","indication_name":"Anogenital warts (external genital warts and perianal warts)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PODOFILOX","company_name":"","drug_phase":"marketed","molecular_target":"Unknown","drug_class":"Topical antiviral","quality_score":60,"revenue":null,"mechanism":"Podofilox induces necrosis of anogenital wart tissue, though the exact mechanism is unknown."}],"pipeline":[],"offLabel":[],"totalMarketed":4,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06700941","title":"Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment","phase":"","overall_status":"COMPLETED","enrollment_count":8000000,"lead_sponsor_name":"Universidad Nacional de Colombia","has_results":false},{"nct_id":"NCT00543543","title":"Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":14840,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT00092534","title":"Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":12167,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT06866574","title":"A Phase III Trial to Evaluate the Efficacy, Immunogenicity and Safety of a Recombinant Human Papillomavirus 9-Valent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) Vaccine (E.Coli) in Chinese Males","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":9300,"lead_sponsor_name":"Xiamen University","has_results":false},{"nct_id":"NCT02653118","title":"Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":4453,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT00092482","title":"Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine (V501-012)(COMPLETED)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3882,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT01651949","title":"Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2520,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT00517309","title":"Study to Test the Safety of HPV Vaccine in Women (V501-011)(COMPLETED)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1877,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT05314023","title":"Immunogenicity and Safety of V503 in Chinese Males 9 Through 19 Years Old (V503-053)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1590,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT03158220","title":"Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1212,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT01047345","title":"A Study of V503, a 9-valent Human Papillomavirus (9vHPV) Vaccine in Females 12-26 Years of Age Who Have Previously Received GARDASIL™ (V503-006)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":924,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT03532776","title":"Comparison Between Podofilox Topical Gel 0.5% and Allergan's Condylox® Gel 0.5% for External Anogenital Warts","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":466,"lead_sponsor_name":"Dermax SA","has_results":true},{"nct_id":"NCT06681636","title":"Effector and Memory Immune Responses to HPV Vaccination in Vietnamese Women Post Virus Exposure","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"National Institute of Hygiene and Epidemiology, Vietnam","has_results":false},{"nct_id":"NCT06915779","title":"Long Term Follow-up of HPV Vaccine in HIV (CTN 236)","phase":"","overall_status":"COMPLETED","enrollment_count":241,"lead_sponsor_name":"University of British Columbia","has_results":false},{"nct_id":"NCT06077032","title":"Chlorhexidine and Garlic Extract as Potential Topical Virucidal Therapeutic Agents of Non-Genital Warts","phase":"NA","overall_status":"UNKNOWN","enrollment_count":90,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT02482428","title":"Efficacy and Tolerability of Topical LFX453 for External Genital Warts","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT02750202","title":"Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"University of Pretoria","has_results":true},{"nct_id":"NCT06587542","title":"Effectivity of Protein Purified Derivative Treatment for Anogenital Warts in HIV Patient","phase":"PHASE2, PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Universitas Padjadjaran","has_results":false},{"nct_id":"NCT05156541","title":"Study of the Efficacy and Safety of the Drug Ingaron (Interferon-gamma) in the Treatment of Anogenital Warts","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"SPP Pharmaclon Ltd.","has_results":false},{"nct_id":"NCT01532102","title":"Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Anaconda Pharma","has_results":false},{"nct_id":"NCT03948321","title":"Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Small Genital Warts","phase":"NA","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Shanghai Dermatology Hospital","has_results":false}],"total":21},"guidelines":[],"source":"Drug Landscape verified database"}